Trials / Unknown
UnknownNCT01647893
Phase 1 Single Dose Escalation Study of CTB-001
A Phase 1 Clinical Study, Randomized, Double-blind, Placebo-controlled, Single-dose, Dose Escalation Study of the Safety and Pharmacokinetic/Pharmacodynamic Profiles of CTB-001 Intravenously Administered in Healthy Male Subjects
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (estimated)
- Sponsor
- HLB Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
A Phase 1 Clinical Study, Randomized, Double-blind, Placebo-controlled, Single-dose, Dose Escalation Study of the Safety and Pharmacokinetic/Pharmacodynamic Profiles of CTB-001 Intravenously Administered in Healthy Male Subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CTB-001 | IV bolus or IV infusion |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-11-01
- Completion
- 2012-12-01
- First posted
- 2012-07-24
- Last updated
- 2012-07-24
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01647893. Inclusion in this directory is not an endorsement.